ProQR Therapeutics N.V.

Contributing Author

Recent Articles by ProQR Therapeutics N.V.

Oct-20	ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 PRQR GlobeNewswire
Oct-13	ProQR to Participate in Upcoming Investor Conferences in October 2025 PRQR GlobeNewswire
Aug-07	ProQR Announces Second Quarter 2025 Operating and Financial Results PRQR GlobeNewswire
Jul-28	ProQR Announces Upcoming Presentation at RNA Editing Summit PRQR GlobeNewswire
Jun-26	ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP PRQR GlobeNewswire
May-12	ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences PRQR GlobeNewswire
May-08	ProQR Announces First Quarter 2025 Operating and Financial Results PRQR GlobeNewswire
May-02	ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference PRQR GlobeNewswire
May-01	ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 PRQR GlobeNewswire